Levodopa/Carbidopa Teva (Levodopa, Carbidopa Monohydrate)

Levodopa serves as a precursor to dopamine. After oral administration, it crosses the blood‑brain barrier and is enzymatically converted into dopamine, compensating for the depleted neurotransmitter in Parkinsonian patients. Carbidopa blocks peripheral conversion, ensuring more levodopa reaches the brain and minimizing gastrointestinal side effects.

The exact dosage of Levodopa/Carbidopa Teva is determined by the prescribing clinician based on the individual’s disease severity, response to therapy, and tolerability. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.

Safety data for Levodopa/Carbidopa in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. It should only be used if the potential benefits justify the potential risks to the fetus or infant, and under close medical supervision.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Levodopa/Carbidopa is considered the most effective symptomatic therapy for Parkinson’s disease because it directly replenishes dopamine. Compared with dopamine agonists, it often provides greater motor improvement but may be associated with earlier development of dyskinesia. The combination reduces peripheral side effects relative to levodopa alone.

Levodopa/Carbidopa Teva tablets should be stored at room temperature, below 25 °C, in their original packaging. Protect them from moisture, excessive heat, and direct sunlight to maintain potency throughout the shelf life.

The medication is taken orally, usually with a glass of water. It can be taken with or without food, but consistent timing with meals may help reduce gastrointestinal discomfort. Patients should follow the dosing schedule prescribed by their healthcare provider.

Serious risks include severe psychiatric reactions such as hallucinations or confusion, neuroleptic malignant syndrome‑like events, and significant cardiovascular effects like arrhythmias or profound hypotension. Any sudden change in mental status or severe cardiovascular symptoms should prompt immediate medical evaluation.

Patients with known hypersensitivity to levodopa, carbidopa, or any excipients should avoid the product. It is also contraindicated in individuals taking non‑selective MAO inhibitors due to the risk of hypertensive crisis, and caution is advised in those with uncontrolled cardiac disease or severe psychiatric disorders.